AIP
BBNX

Ameritas Investment Partners’s Beta Bionics BBNX Stock Holding History

Ameritas Investment Partners’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.1K Hold
3,202
– – ﹤0.01% 2355
2025
Q4 		$97.6K Hold
3,202
– – ﹤0.01% 1715
2025
Q3 		$63.6K Buy
3,202
+1,863
+139% +$32.7K ﹤0.01% 1964
2025
Q2 		$19.5K Hold
1,339
– – ﹤0.01% 2670
2025
Q1 		$16.4K Buy
+1,339
New +$25K ﹤0.01% 2639

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameritas Investment Partners's BBNX Position: Q1 2026 in Review

Ameritas Investment Partners held its Beta Bionics (BBNX) position steady in Q1 2026 at 3,202 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2355.

Ameritas Investment Partners first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $97.6K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Ameritas Investment Partners held 3,202 shares of Beta Bionics worth $32.1K as of Q1 2026.
  • Ameritas Investment Partners left its Beta Bionics share count unchanged in Q1 2026.
  • Beta Bionics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2355 holding.
  • Ameritas Investment Partners first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Ameritas Investment Partners's Beta Bionics position peaked at $97.6K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.